NEW YORK (GenomeWeb) - GenMark Diagnostics reported after the close of the market on Thursday a 17 percent rise in second quarter revenues, an increase driven by the placement of 29 XT-8 molecular diagnostic systems during the period, bringing the total number of installed systems in the US to 591.

For the three-month period ended June 30, GenMark's revenues rose to $7.6 million from $6.6 million in Q2 2014, in line with the consensus Wall Street estimate.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.